Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes? (Q32143682)

6 July 2017

1 reference

title

Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes? (English)

1 reference

6 July 2017

1 reference

Gordon YJ

1

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

American Journal of Ophthalmology

6 July 2017

published in

1 reference

6 July 2017

volume

131

1 reference

6 July 2017

issue

3

1 reference

6 July 2017

page(s)

371-376

1 reference

Filters and Antibiotics in Irrigating Solution for Cataract Surgery

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Emergence of vancomycin resistance in coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

New resistance in Staphylococcus aureus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Epidemiology of resistance to antibiotics. Links between animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Historical yearly usage of vancomycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Perioperative antibiotic prophylaxis in cataract surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Preventing, diagnosing, and treating endophthalmitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Endophthalmitis in cataract surgery: results of a German survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Anterior Chamber Contamination After Uncomplicated Phacoemulsification and Intraocular Lens Implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Postoperative contamination after using vancomycin and gentamicin during phacoemulsification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Vancomycin prophylaxis and intraocular contamination during cataract surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Coagulase-negative Staphylococcus endophthalmitis after cataract surgery with intraocular vancomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Antibiotic supplementation of intraocular irrigating solutions. An in vitro model of antibacterial action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Emergence of vancomycin tolerance in Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

Cystoid macular edema after cataract surgery with intraocular vancomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900955-7

10.1016/S0002-9394(00)00955-7

7 January 2021

Identifiers

DOI

1 reference

6 July 2017

1 reference